Calciotropic Effects After HCG Stimulation Test
NCT03254641 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242
Last updated 2024-11-15
Summary
We have in a pilot study found that serum calcium levels change in response to hCG stimulation test. We observed that serum calcium level measured at baseline and 72 hours after hCG stimulation were different in men with gonadal insufficiency referred for this stimulation test. Now we want to investigate a large cohort of men referred for hCG stimulation test due to suspected impaired gonadal function.
Conditions
- Hypogonadism, Male
Interventions
- DRUG
-
human chorionic gonadotropin
5000 IE times one
Sponsors & Collaborators
-
Martin Blomberg Jensen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-04-01
- Primary Completion
- 2020-09-30
- Completion
- 2021-10-06
Countries
- Denmark
Study Locations
More Related Trials
-
Phlebotomy Study of Testosterone Undecanoate
NCT02670343 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
Diurnal Testosterone Concentration
NCT03091296 ·Status: COMPLETED
-
Pharmacokinetic Study to Determine Time to Steady-state
NCT00911586 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)
NCT03687606 ·Status: UNKNOWN ·Phase: PHASE4
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
NCT01403116 ·Status: COMPLETED ·Phase: PHASE3
-
Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
NCT04189133 ·Status: RECRUITING ·Phase: PHASE2
-
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
NCT01993225 ·Status: COMPLETED ·Phase: PHASE3
-
Sequential Therapy for Hypogonadotropic Hypogonadism
NCT01403532 ·Status: COMPLETED ·Phase: PHASE4
-
Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
NCT00700024 ·Status: UNKNOWN ·Phase: PHASE4
-
Testosterone Treatment for Hypogonadal Men
NCT00433199 ·Status: COMPLETED ·Phase: PHASE3
-
Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
NCT00223860 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
NCT01993212 ·Status: COMPLETED ·Phase: PHASE3
-
A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
NCT01386567 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
NCT03887936 ·Status: COMPLETED ·Phase: PHASE4
-
Testosterone Therapy in Hypogonadal Men Treated With Opioids
NCT02433730 ·Status: COMPLETED ·Phase: PHASE4
-
Opioid Antagonism in Hypogonadotropic Hypogonadism
NCT04975334 ·Status: COMPLETED ·Phase: PHASE1
-
Does Testosterone Improve Function in Hypogonadal Older Men
NCT00304213 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety of Testosterone Undecanoate i.m. in Hypogonadal Men
NCT00452322 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)
NCT03118479 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
NCT02149264 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Trial of Testosterone Undecanoate
NCT01765179 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
NCT01699178 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
NCT04274894 ·Status: COMPLETED ·Phase: PHASE4